Skip to main content
. 2023 Mar 1;14:1126351. doi: 10.3389/fimmu.2023.1126351

Figure 2.

Figure 2

Anti-S-antibody titer (log-transformed) according to vaccination status, PCR status (positive or negative) and treatment modality (anti-TNF or vedolizumab*).